First Time Loading...

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 109.29 USD -0.92% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one JAZZ stock under the Base Case scenario is 462.66 USD. Compared to the current market price of 109.29 USD, Jazz Pharmaceuticals PLC is Undervalued by 76%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JAZZ Relative Value
Base Case
462.66 USD
Undervaluation 76%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
98
vs Industry
57
Median 3Y
2.6
Median 5Y
2.8
Industry
2.4
Forward
1.6
More Details
16.4
P/E
P/E
Price to Earnings
16.4
vs History
42
vs Industry
28
Median 3Y
-25.7
Median 5Y
14.7
Industry
22.9
Forward
5.6
More Details
6.2
P/OCF
P/OCF
Price to OCF
6.2
vs History
90
vs Industry
43
Median 3Y
8.3
Median 5Y
8.9
Industry
17.1
More Details
12.4
P/FCFE
P/FCFE
Price to FCFE
12.4
vs History
38
vs Industry
28
Median 3Y
9.6
Median 5Y
10.4
Industry
23.2
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
98
vs Industry
42
Median 3Y
2.5
Median 5Y
2.5
Industry
2.1
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
96
vs Industry
42
Median 3Y
3.9
Median 5Y
3.8
Industry
2.6
Forward
2.5
More Details
3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3
vs History
95
vs Industry
61
Median 3Y
4.4
Median 5Y
4.2
Industry
5.1
More Details
7.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.9
vs History
96
vs Industry
40
Median 3Y
14.6
Median 5Y
10.9
Industry
13.6
Forward
5.6
More Details
15.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.6
vs History
73
vs Industry
30
Median 3Y
33.8
Median 5Y
19.8
Industry
17
Forward
5.7
More Details
9.4
EV/OCF
EV/OCF
Enterprise Value to OCF
9.4
vs History
73
vs Industry
38
Median 3Y
11.6
Median 5Y
10
Industry
15.8
More Details
9.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9.8
vs History
98
vs Industry
29
Median 3Y
14.9
Median 5Y
14.1
Industry
17.6
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
98
vs Industry
56
Median 3Y
1.3
Median 5Y
1.5
Industry
1.9
More Details

Multiples Across Competitors

JAZZ Competitors Multiples
Jazz Pharmaceuticals PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
6.8B USD 1.8 16.4 7.9 15.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
717.6B USD 21 136.9 61.8 71
DK
Novo Nordisk A/S
CSE:NOVO B
3.7T DKK 16 44.8 32.7 35.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
360.9B USD 4.4 8.9 11.9 15.7
US
Merck & Co Inc
NYSE:MRK
324.7B USD 5.3 140.8 33.5 53.1
UK
AstraZeneca PLC
LSE:AZN
187.8B GBP 5.1 39.5 140.7 225.8
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.3 13.4 9.8 16.2
CH
Roche Holding AG
SIX:ROG
172.7B CHF 2.9 15 8.6 10.2
US
Pfizer Inc
NYSE:PFE
156.4B USD 2.7 73.8 11 16.3

See Also

Summary
JAZZ intrinsic value, competitors valuation, and company profile.
DCF Valuation
JAZZ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JAZZ stock valuation using valuation multiples.
Wall Street Estimates
JAZZ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JAZZ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.